e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Immunology in interstitial lung disease and airway infectious problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The importance of pneumococcal and influenza vaccines in patients with allergic asthma
J. Strakova, T. Baska, R. Madar (Martin, Slovakia; Ostrava, Czech Republic)
Source:
Annual Congress 2005 - Immunology in interstitial lung disease and airway infectious problems
Session:
Immunology in interstitial lung disease and airway infectious problems
Session type:
Thematic Poster Session
Number:
2426
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Strakova, T. Baska, R. Madar (Martin, Slovakia; Ostrava, Czech Republic). The importance of pneumococcal and influenza vaccines in patients with allergic asthma. Eur Respir J 2005; 26: Suppl. 49, 2426
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004
Seasonal influenza vaccination rates in chronic asthma patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Evolution of influenza vaccination coverages in Spanish patients with asthma or chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Impact vaccination against pneumococcal infection for clinical-functional indexes and course of bronchial asthma in children
Source: Eur Respir J 2004; 24: Suppl. 48, 611s
Year: 2004
Should pneumococcal vaccines be used to prevent LRTI?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Influenza A virus in exacerbation of asthma within scool children
Source: Eur Respir J 2003; 22: Suppl. 45, 500s
Year: 2003
Pneumococcal vaccine in steroid-dependent COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
Comparison of efficacy of grippe vaccination in asthma and COPD patients
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Factors affecting vaccination rates against influenza in adults with asthma
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications
Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Year: 2008
Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012
Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept